摘要
目的 分析喜炎平注射液治疗上呼吸道感染的临床疗效. 方法 整群选取2014年6月—2015年5月来该校卫生所就诊的上呼吸道感染患者144例,随机分为对照组和治疗组.两组患者均有72例.给予对照组利巴韦林,给予观察组喜炎平注射液, 观察两组的临床疗效和不良反应. 结果 对照组的总有效率为69.45%, 治疗组的总有效率为91.67%. 两组数据进行比较,治疗组的总有效率明显优于对照组,统计学处理后差异有统计学意义（χ2=10.80 P〈0.05）.对照组的总不良反应率为12.50%,治疗组的总不良反应率为11.11%,治疗组的不良反应率高于对照组. 两组患者不良反应发生率进行比较,差异无统计学意义（P〉0.05）. 结论 喜炎平注射液用于治疗上呼吸道感染疾病具有较好的疗效,但是不良反应较普通抗病毒药物略高.
Objective To analyze the clinical efficacy of xiyanping in treating upper respiratory tract infection. Methods 144 patients with upper respiratory tract infection receiving treatment in the clinic of the college from June 2014 and May 2015 were randomly divided into control group and treatment group with 72 patients in each one. The control group was treated with ribavirin injection, while the observation group was treated with xiyanping injection. The clinical efficacy and adverse reaction of the two groups were observed. Results The total effective rate was 69.45% in the control group and 91.67%in the control group, and comparison between the data of the two groups showed that the total effective rate was bet-ter in the treatment group than in the control group, and there was statistically significant difference between them accord-ing to the results statistical analysis, （χ2=10.80, P〈0.05）. The incidence of adverse reaction was 12.50% in the treatment group, higher than that which was 11.11% in the control group, and the difference between them is not statistically signifi-cant, （P〉0.05）. Conclusion Xiyanping injection, compared with other common antiviral drugs, has better efficacy but a little more adverse reaction in the treatment of upper respiratory tract infection.
出处
《中外医疗》
2015年第32期144-145,共2页
China & Foreign Medical Treatment
关键词
喜炎平注射液
上呼吸道感染
利巴韦林
Xiyanping injection
Upper respiratory tract infection
Ribavirin
